@inproceedings{inproceedings, title  = {{MO2 - MODELLING OVERALL SURVIVAL IN IMMUNOTHERAPY USING PARAMETRIC TECHNIQUES: AVELUMAB IN PREVIOUSLY TREATED METASTATIC MERKEL CELL CARCINOMA}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2018}},

 month = {{10}},

 author = {{Bullement A and Amin A and Stapelkamp C and Willis A and Lilley C and Hatswell AJ and Pescott C and Bharmal M}},

 doi = {{10.1016/j.jval.2018.09.062}},

 volume = {{21}},

 journal = {{Value in Health}},

 pages = {{S11-S11}},

 note = {{Accessed on 2024/12/22}}}